The Alteration and Clinical Significance of Th1/Th2/Th17/Treg Cells in Patients with Multiple Myeloma

Inflammation

Volumn 38, Issue 2, 2015, Pages 705-709

  Feng, Ping ^a   Yan, Ruhong ^a   Dai, Xiaoli ^a   Xie, Xiaofang ^a   Wen, Huiyan ^a   Yang, Shun ^a  

^a THE SECOND AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

multiple myeloma; Th1; Th17; Th2; Treg

Indexed keywords

CYTOKINE;

ADOLESCENT; ADULT; AGED; FEMALE; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; MULTIPLE MYELOMA; REGULATORY T LYMPHOCYTE; TH1 CELL; TH17 CELL; TH2 CELL; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CYTOKINES; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE MYELOMA; T-LYMPHOCYTES, REGULATORY; TH1 CELLS; TH17 CELLS; TH2 CELLS; YOUNG ADULT;

EID: 84939881911     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-014-9980-4     Document Type: Article

References (17)

1. Sedlarikova, L., et al. 2014. Cytokine profiles of multiple myeloma and Waldenstrom macroglobulinemia. Klinická Onkologie 27(1): 18–23.
2. Mehtap, O., et al. 2014. IL-21 and other serum proinflammatory cytokine levels in patients with multiple myeloma at diagnosis. Journal of Postgraduate Medicine 60(2): 141–4.
3. Song, X.N., et al. 2013. Expression levels of IL-27 and IL-17 in multiple myeloma patients: a higher ratio of IL-27:IL-17 in bone marrow was associated with a superior progression-free survival. Leukemia Research 37(9): 1094–9.
4. Abbas, A.K., K.M. Murphy, and A. Sher. 1996. Functional diversity of helper T lymphocytes. Nature 383(6603): 787–93.
5. Mosmann, T.R., and S. Sad. 1996. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunology Today 17(3): 138–46.
6. Park, H., et al. 2005. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nature Immunology 6(11): 1133–41.
7. Bettelli, E., M. Oukka, and V.K. Kuchroo. 2007. T(H)-17 cells in the circle of immunity and autoimmunity. Nature Immunology 8(4): 345–50.
8. Komiyama, Y., et al. 2006. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. Journal of Immunology 177(1): 566–73.
9. Sakaguchi, S., et al. 2006. Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunology Reviews 212: 8–27.
10. Ryba-Stanislawowska, M., et al. 2013. Loss of the balance between CD4(+)Foxp3(+) regulatory T cells and CD4(+)IL17A(+) Th17 cells in patients with type 1 diabetes. Human Immunology 74(6): 701–7.
11. Boissier, M.C., et al. 2008. Shifting the imbalance from Th1/Th2 to Th17/treg: the changing rheumatoid arthritis paradigm. Joint, Bone, Spine 75(4): 373–5.
12. Cheng, X., et al. 2008. The Th17/Treg imbalance in patients with acute coronary syndrome. Clinical Immunology 127(1): 89–97.
13. Zhang, Y., et al. 2013. Function of peripheral blood Th17 cells in patients with multiple myeloma. Zhongguo Shi Yan Xue Ye Xue Za Zhi 21(5): 1187–9.
14. Jandus, C., et al. 2008. Increased numbers of circulating polyfunctional Th17 memory cells in patients with seronegative spondylarthritides. Arthritis and Rheumatism 58(8): 2307–17.
15. Elias, K.M., et al. 2008. Retinoic acid inhibits Th17 polarization and enhances FoxP3 expression through a Stat-3/Stat-5 independent signaling pathway. Blood 111(3): 1013–20.
16. Gavin, M.A., et al. 2007. Foxp3-dependent programme of regulatory T-cell differentiation. Nature 445(7129): 771–5.
17. Wang, X., et al. 2009. Expression of IL-23 and IL-17 and effect of IL-23 on IL-17 production in ankylosing spondylitis. Rheumatology International 29(11): 1343–7.